Escalon Medical(ESMC)
$0.19+0.01 (+5.56%)
ESMC
Escalon Medical financials statements
$0.19
At close:+0.01 (+5.56%)
Escalon Medical (ESMC) Ratios
12 Followers
Escalon Medical Ratios
ESMC's free cash flow for Q4 2026 was $-251.18M. For the 2026 fiscal year, ESMC's free cash flow was decreased by $-4.41K and operating cash flow was $-251.18M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.94 | 1.72 | 1.65 | 1.63 | 1.39 |
| Quick Ratio | -723.04 | -796.07 | 1.04 | 1.07 | 0.86 |
| Cash Ratio | 1283.43 | 203.27 | 0.08 | 0.31 | 0.20 |
| Solvency Ratio | 1.26 | 0.05 | -0.03 | 0.15 | 0.09 |
| Operating Cash Flow Ratio | -168.56 | 0.14 | -0.23 | 0.11 | -0.35 |
| Short-Term Operating Cash Flow Coverage | -115062.59 | 8.64 | -16.14 | 8.09 | -5.05 |
| Net Current Asset Value | $ 3.81M | $ 1.53M | $ 1.45M | $ 1.26M | $ 491.56K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.10 | 0.11 | 0.17 | 0.23 |
| Debt-to-Equity Ratio | 0.16 | 0.27 | 0.29 | 0.46 | 0.82 |
| Debt-to-Capital Ratio | 0.14 | 0.21 | 0.22 | 0.32 | 0.45 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.11 | 0.13 | 0.14 | 0.09 |
| Financial Leverage Ratio | 1.54 | 2.61 | 2.63 | 2.74 | 3.50 |
| Debt Service Coverage Ratio | -97.79 | 0.01 | -1.01 | 8.46 | 1.61 |
| Interest Coverage Ratio | 6.06 | 0.01 | -5.03 | 22.04 | 1.98 |
| Debt to Market Cap | 0.09 | 0.11 | 0.29 | 0.19 | 0.39 |
| Interest Debt Per Share | 0.13 | 3.13 | 0.07 | 0.12 | 0.16 |
| Net Debt to EBITDA | -45183.69 | -3284.30 | -5.40 | 0.00 | 1.68 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.73% | 45.75% | 42.95% | 45.00% | 43.04% |
| EBIT Margin | 0.36% | 1.06% | -0.87% | 3.93% | 0.34% |
| EBITDA Margin | 0.53% | 1.38% | -0.49% | 4.30% | 3.41% |
| Operating Profit Margin | 0.36% | 1.11% | -0.87% | 3.93% | 0.34% |
| Pretax Profit Margin | 22.56% | 0.88% | -1.05% | 3.75% | 0.17% |
| Net Profit Margin | 31.51% | 0.88% | -1.05% | 3.75% | 0.17% |
| Continuous Operations Profit Margin | 31.51% | 0.88% | -1.05% | 3.75% | 0.17% |
| Net Income Per EBT | 139.66% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 6351.67% | 79.21% | 119.89% | 95.46% | 49.55% |
| Return on Assets (ROA) | 43.96% | 2.11% | -2.63% | 8.61% | 0.35% |
| Return on Equity (ROE) | 67.69% | 5.51% | -6.92% | 23.61% | 1.22% |
| Return on Capital Employed (ROCE) | 0.67% | 5.77% | -5.00% | 19.49% | 1.68% |
| Return on Invested Capital (ROIC) | 0.40% | 5.46% | -4.48% | 16.94% | 1.36% |
| Return on Tangible Assets | 44.00% | 2.13% | -2.66% | 8.72% | 0.36% |
| Earnings Yield | 270.56% | 4.40% | -11.85% | 24.64% | 1.93% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.69 | 0.01 | 5.64 | 7.37 | 6.94 |
| Payables Turnover | 7.72 | 0.00 | 5.04 | 5.56 | 6.02 |
| Inventory Turnover | 0.00 | 0.00 | 4.24 | 4.22 | 3.80 |
| Fixed Asset Turnover | 0.01 | 0.04 | 48.14 | 22.65 | 12.73 |
| Asset Turnover | 1.40 | 2.41 | 2.52 | 2.29 | 2.07 |
| Working Capital Turnover Ratio | 3.89 | 6.59 | 6.82 | 8.21 | 9.00 |
| Cash Conversion Cycle | 88320.17 | 92694.75 | 78.37 | 70.40 | 87.99 |
| Days of Sales Outstanding | 54.54 | 50522.28 | 64.71 | 49.56 | 52.58 |
| Days of Inventory Outstanding | 88312.92 | 119650.38 | 86.14 | 86.52 | 96.03 |
| Days of Payables Outstanding | 47.29 | 77477.90 | 72.47 | 65.68 | 60.62 |
| Operating Cycle | 88367.46 | 170172.65 | 150.85 | 136.08 | 148.61 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -54.29 | 0.05 | -0.08 | 0.04 | -0.14 |
| Free Cash Flow Per Share | -54.29 | 0.05 | -0.09 | 0.04 | -0.14 |
| Dividend Paid and CapEx Coverage Ratio | -91169.38 | 0.00 | -14.96 | 23.49 | 0.00 |
| Capital Expenditure Coverage Ratio | -91169.38 | 0.00 | -14.96 | 23.49 | 0.00 |
| Operating Cash Flow Coverage Ratio | -413.04 | 0.73 | -1.15 | 0.37 | -0.87 |
| Operating Cash Flow to Sales Ratio | -31.61 | 0.03 | -0.05 | 0.03 | -0.10 |
| Free Cash Flow Yield | -27146.74% | 15.86% | -60.86% | 16.79% | -111.88% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 0.74 | 85.19 | -8.44 | 4.06 | 51.90 |
| Price-to-Sales (P/S) Ratio | 0.12 | 0.20 | 0.09 | 0.15 | 0.09 |
| Price-to-Book (P/B) Ratio | 0.25 | 1.25 | 0.58 | 0.96 | 0.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.00 | 6.31 | -1.64 | 5.96 | -0.89 |
| Price-to-Operating Cash Flow Ratio | -0.00 | 6.31 | -1.75 | 5.70 | -0.89 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.74 | 0.06 | 0.00 | -0.42 |
| Enterprise Value Multiple | -45161.82 | -3269.84 | -23.47 | 3.54 | 4.25 |
| Enterprise Value | -3.06B | -542.91M | 1.37M | 1.85M | 1.55M |
| EV to EBITDA | -45161.82 | -3269.84 | -23.47 | 3.54 | 4.25 |
| EV to Sales | -240.50 | -45.07 | 0.11 | 0.15 | 0.14 |
| EV to Free Cash Flow | 7.61 | -1425.99 | -2.13 | 5.96 | -1.48 |
| EV to Operating Cash Flow | 7.61 | -1425.99 | -2.28 | 5.70 | -1.48 |
| Tangible Book Value Per Share | 0.80 | 0.25 | 0.24 | 0.25 | 0.19 |
| Shareholders’ Equity Per Share | 0.80 | 0.26 | 0.24 | 0.26 | 0.20 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.72 | 1.62 | 1.62 | 1.64 | 1.44 |
| Net Income Per Share | 0.54 | 0.01 | -0.02 | 0.06 | 0.00 |
| Tax Burden | 1.40 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 63.52 | 0.82 | 1.20 | 0.95 | 0.50 |
| Research & Development to Revenue | 39.38 | 62.52 | 0.06 | 0.07 | 0.09 |
| SG&A to Revenue | 394.37 | 383.92 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.10 | 3.61 | 4.81 | 0.71 | -58.07 |
Currency in USD
